Prehospital stroke care New prospects for treatment and clinical research

Neurology

Volumn 81, Issue 5, 2013, Pages 501-508

  Audebert, Heinrich J ^a   Saver, Jeffrey L ^b   Starkman, Sidney ^b   Lees, Kennedy R ^c   Endres, Matthias ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LISINOPRIL; MAGNESIUM;

CEREBROVASCULAR ACCIDENT; CLINICAL EXAMINATION; CLINICAL RESEARCH; COMPUTED TOMOGRAPHY SCANNER; EMERGENCY CARE; FIBRINOLYTIC THERAPY; HUMAN; NEUROPROTECTION; PRIORITY JOURNAL; REVIEW; STROKE PATIENT; TELEMEDICINE; TIME TO TREATMENT;

BIOMEDICAL RESEARCH; EMERGENCY MEDICAL SERVICES; HUMANS; STROKE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84881294750     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e31829e0fdd     Document Type: Review

References (62)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333:1581-1587.
2. Lees KR, Bluhmki E, von Kummer R, et al. Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 2010;375:1695-1703.
3. Hacke W, Kaste M, Bluhmki E, et al. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317-1329.
4. Sandercock P, Wardlaw JM, Lindley RI, et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012;379:2352-2363.
5. Leys D, Ringelstein EB, Kaste M, Hacke W. Facilities available in European hospitals treating stroke patients. Stroke 2007;38:2985-2991.
6. Weber JE, Ebinger M, Rozanski M, et al. Prehospital thrombolysis in acute stroke: results of the PHANTOM-S pilot study. Neurology 2013;80:163-168.
7. Walter S, Kostopoulos P, Haass A, et al. Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trial. Lancet Neurol 2012;11:397-404.
8. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999;22:391-397.
9. ÖCollins VE, Macleod MR, Donnan GA, et al. 1,026 experimental treatments in acute stroke. Ann Neurol 2006;59:467-477.
10. Endres M, Engelhardt B, Koistinaho J, et al. Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis 2008;25:268-278.
11. Murata Y, Rosell A, Scannevin RH, et al. Extension of the thrombolytic time window with minocycline in experimental stroke. Stroke 2008;39:3372-3377.
12. Donnan GA, Baron JC, Ma H, Davis SM. Penumbral selection of patients for trials of acute stroke therapy. Lancet Neurol 2009;8:261-269.
13. Alldredge BK, Gelb AM, Isaacs SM, et al. A comparison of lorazepam, diazepam, and placebo for the treatment of out-of-hospital status epilepticus. N Engl J Med 2001; 345:631-637.
14. Bernard SA, Gray TW, Buist MD, et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002;346:557-563.
15. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002;346: 549-556.
16. James M, Monks T, Pitt M, Stein K. Increasing the Proportion of patients treated with thrombolysis: reducing in-hospital delays has substantially more Impact than extension of the time window. Cerebrovasc Dis 2012;(suppl 2):p602-p603.
17. Wahlgren N, Ahmed N, Davalos A, et al. Thrombolysis with alteplase 3-4.5 h after acute ischaemic stroke (SITS-ISTR): an observational study. Lancet 2008;372:1303-1309.
18. Fonarow GC, Smith EE, Saver JL, et al. Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation 2011;123:750-758.
19. Walter S, Kostopoulos P, Haass A, et al. Point-of-care laboratory halves door-to-therapy-decision time in acute stroke. Ann Neurol 2011;69:581-586.
20. Meretoja A, Strbian D, Mustanoja S, et al. Reducing inhospital delay to 20 minutes in stroke thrombolysis. Neurology 2012;79:306-313.
21. Kohrmann M, Schellinger PD, Breuer L, et al. Avoiding in hospital delays and eliminating the three-hour effect in thrombolysis for stroke. Int J Stroke 2011;6:493-497.
22. Lecouturier J, Rodgers H, Murtagh MJ, et al. Systematic review of mass media interventions designed to improve public recognition of stroke symptoms, emergency response and early treatment. BMC Public Health 2010;10:784.
23. Lin CB, Peterson ED, Smith EE, et al. Emergency medical service hospital prenotification is associated with improved evaluation and treatment of acute ischemic stroke. Circ Cardiovasc Qual Outcomes 2012;5:514-522.
24. Buck BH, Starkman S, Eckstein M, et al. Dispatcher recognition of stroke using the National Academy Medical Priority Dispatch System. Stroke 2009;40:2027-2030.
25. Govindarajan P, Ghilarducci D, McCulloch C, et al. Comparative evaluation of stroke triage algorithms for emergency medical dispatchers (MeDS): prospective cohort study protocol. BMC Neurol 2011;11:14.
26. Ramanujam P, Guluma KZ, Castillo EM, et al. Accuracy of stroke recognition by emergency medical dispatchers and paramedics-San Diego experience. Prehosp Emerg Care 2008;12:307-313.
27. Berglund A, Svensson L, Sjostrand C, et al. Higher prehospital priority level of stroke improves thrombolysis frequency and time to stroke unit: the Hyper Acute STroke Alarm (HASTA) study. Stroke 2012;43:2666-2670.
28. Kidwell CS, Starkman S, Eckstein M, Weems K, Saver JL. Identifying stroke in the field. Prospective validation of the Los Angeles prehospital stroke screen (LAPSS). Stroke 2000;31: 71-76.
29. Bray JE, Martin J, Cooper G, et al. Paramedic identification of stroke: community validation of the Melbourne ambulance stroke screen. Cerebrovasc Dis 2005;20:28-33.
30. Kothari RU, Pancioli A, Liu T, Brott T, Broderick J. Cincinnati Prehospital Stroke Scale: reproducibility and validity. Ann Emerg Med 1999;33:373-378.
31. Harbison J, Hossain O, Jenkinson D, et al. Diagnostic accuracy of stroke referrals from primary care, emergency room physicians, and ambulance staff using the face arm speech test. Stroke 2003;34:71-76.
32. Bergrath S, Reich A, Rossaint R, et al. Feasibility of prehospital teleconsultation in acute stroke: a pilot study in clinical routine. PLoS One 2012;7:e36796.
33. Liman TG, Winter B, Waldschmidt C, et al. Telestroke ambulances in prehospital stroke management: concept and pilot feasibility study. Stroke 2012;43:2086-2090.
34. Audebert HJ, Kukla C, Clarmann von Claranau S, et al. Telemedicine for safe and extended use of thrombolysis in stroke: the Telemedic Pilot Project for Integrative Stroke Care (TEMPiS) in Bavaria. Stroke 2005;36:287-291.
35. Schlachetzki F, Herzberg M, Holscher T, et al. Transcranial ultrasound from diagnosis to early stroke treatment: part 2: prehospital neurosonography in patients with acute stroke: the Regensburg stroke mobile project. Cerebrovasc Dis 2012;33:262-271.
36. Prehospital Transcranial Duplex in Patients with Acute Stroke. 2012. Available at: http://clinicaltrials.gov/ct2/show/NCT01069276. Accessed April 29, 2013.
37. Holscher T, Dunford JV, Schlachetzki F, et al. Prehospital stroke diagnosis and treatment in ambulances and helicopters-A concept paper. Am J Emerg Med 2013;31:743-747.
38. Ankolekar S, Sare G, Geeganage C, et al. Determining the feasibility of ambulance-based randomised controlled trials in patients with ultra-acute stroke: study protocol for the Rapid Intervention with GTN in Hypertensive Stroke Trial (RIGHT, ISRCTN66434824). Stroke Res Treat 2012;2012:385753.
39. Shaw L, Price C, McLure S, et al. Paramedic Initiated Lisinopril For Acute Stroke Treatment (PIL-FAST): study protocol for a pilot randomised controlled trial. Trials 2011;12:152.
40. Nurmi J, Lindsberg PJ, Happola O, et al. Strict glucose control after acute stroke can be provided in the prehospital setting. Acad Emerg Med 2011;18:436-439.
41. Field Administration of Stroke Therapy-Magnesium (FAST-MAG) trial. 2012. Available at: http://clinicaltrials. gov/ct2/show/NCT00059332. Accessed May 3, 2012.
42. Izumi Y, Roussel S, Pinard E, Seylaz J. Reduction of infarct volume by magnesium after middle cerebral artery occlusion in rats. J Cereb Blood Flow Metab 1991;11:1025-1030.
43. Muir KW, Lees KR, Ford I, Davis S. Magnesium for acute stroke (Intravenous Magnesium Efficacy in Stroke trial): randomised controlled trial. Lancet 2004;363:439-445.
44. Nazliel B, Starkman S, Liebeskind DS, et al. A brief prehospital stroke severity scale identifies ischemic stroke patients harboring persisting large arterial occlusions. Stroke 2008;39:2264-2267.
45. Sanossian N, Starkman S, Liebeskind DS, et al. Simultaneous ring voice-over-Internet phone system enables rapid physician elicitation of explicit informed consent in prehospital stroke treatment trials. Cerebrovasc Dis 2009;28:539-544.
46. Saver JL, Eckstein M, Stratton S, Pratt F, et al; for the FAST-MAG Investigators and Nurse-Coordinators. Field Administration of Stroke Therapy-Magnesium (FASTMAG) Phase 3 Trial. Ongoing Clinical Trial Poster Session Abstract Booklet. New Orleans: International Stroke Conference; 2012.
47. Sanossian NK-TM, Starkman S, Liebeskind DS, et al; for the FAST-MAG Investigators and Coordinators. Field neuroprotective therapy followed by intravenous thrombolysis in a phase 3 clinical trial. Stroke 2012;43:A65.
48. Fassbender K, Walter S, Liu Y, et al. "Mobile stroke unit" for hyperacute stroke treatment. Stroke 2003;34:e44.
49. PHANTOM-S. The pre-hospital acute neurological therapy and optimization of medical care in stroke patients study. 2012. Available at: http://clinicaltrials.gov/ct2/show/NCT01382862. Accessed April 29, 2013.
50. Krebes S, Ebinger M, Baumann AM, et al. Development and validation of a dispatcher identification algorithm for stroke emergencies. Stroke 2012;43:776-781.
51. Ebinger M, Rozanski M, Waldschmidt C, et al. PHANTOM-S: the prehospital acute neurological therapy and optimization of medical care in stroke patients study. Int J Stroke 2012;7:348-353.
52. Hodgson C, Lindsay P, Rubini F. Can mass media influence emergency department visits for stroke? Stroke 2007; 38:2115-2122.
53. Flibotte JJ, Hagan N, ÖDonnell J, Greenberg SM, Rosand J. Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage. Neurology 2004; 63:1059-1064.
54. Sun L, Zhou W, Ploen R, et al. Rapid reversal of anticoagulation prevents excessive secondary hemorrhage after thrombolysis in a thromboembolic model in rats. Stroke 2011;42:3524-3529.
55. Morgenstern LB, Hemphill JC 3rd, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010;41:2108-2129.
56. Kostopoulos P, Walter S, Haass A, et al. Mobile stroke unit for diagnosis-based triage of persons with suspected stroke. Neurology 2012;78:1849-1852.
57. Bath P. RT: The RIGHT Trial: Rapid Intervention with Glyceryl Trinitrate (GTN) in Hypertensive Stroke; ISRCTN66434824. 2012. Available at: http://www.right-trial.org/rightprotocolv11.pdf. Accessed April 29, 2013.
58. Foerch C, Niessner M, Back T, et al. Diagnostic accuracy of plasma glial fibrillary acidic protein for differentiating intracerebral hemorrhage and cerebral ischemia in patients with symptoms of acute stroke. Clin Chem 2012;58:237-245.
59. Adams HP Jr, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007;115:e478-e534.
60. Mayer SA, Brun NC, Begtrup K, et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008;358:2127-2137.
61. Mayer SA, Davis SM, Skolnick BE, et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII? Stroke 2009;40:833-840.
62. Efficacy and safety of MRI-based thrombolysis in wake-up stroke (WAKE-UP). Available at: http://clinicaltrials.gov/ct2/show/NCT01525290? term5wake-up&rank51. Accessed June 15, 2012.